{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:50:56Z","timestamp":1791481856561,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05980-9","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:33:11Z","timestamp":1791433991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydroxysafflor yellow A attenuates microcirculatory disturbance in MAFLD via the EGFR\/MAPK1 pathway"],"prefix":"10.1007","author":[{"given":"Qing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"5980_CR1","first-page":"229","volume":"40","author":"N Ai","year":"2025","unstructured":"Ai N, Wang XC, Liu XY, Liu Q, Wang R, Yang J (2025) Research progress on hepatoprotective effects of hydroxysafflor yellow A. Drugs Clin 40:229\u2013233","journal-title":"Drugs Clin"},{"key":"5980_CR2","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1073\/pnas.0804543106","volume":"106","author":"K Al-Nedawi","year":"2009","unstructured":"Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 106:3794\u20133799. https:\/\/doi.org\/10.1073\/pnas.0804543106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5980_CR3","doi-asserted-by":"publisher","unstructured":"Alsalman ZM, Zhu QJ, Hu JY, et al (2025) Roles of mitochondrial quality control in the pathogenesis of atherosclerosis. Cardiovasc Innov Appl 10:1\u201315. https:\/\/doi.org\/10.15212\/CVIA.2025.0013","DOI":"10.15212\/CVIA.2025.0013"},{"key":"5980_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/0115701646341608241025030547","author":"S Bansal","year":"2024","unstructured":"Bansal S, Burman A, Sen A et al (2024) Decoding glycobiomarkers in non-alcoholic steatohepatitis (NASH) and related hepatocellular carcinoma (HCC). Curr Proteomics. https:\/\/doi.org\/10.2174\/0115701646341608241025030547","journal-title":"Curr Proteomics"},{"issue":"4","key":"5980_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/0115701646301720240830070246","volume":"21","author":"A Berdowska","year":"2024","unstructured":"Berdowska A, Berdowska S (2024) Advances in research on adropin: potential implications for clinical diagnosis and possible treatment \u2013 a mini-review. Curr Proteomics 21(4):205\u2013216","journal-title":"Curr Proteomics"},{"key":"5980_CR6","doi-asserted-by":"publisher","unstructured":"Berezin AZ (2024) The plausible role of vascular adhesion molecules in cardiovascular diseases. Cardiovasc Innov Appl 9:1\u20134. https:\/\/doi.org\/10.15212\/CVIA.2024.0046.","DOI":"10.15212\/CVIA.2024.0046"},{"key":"5980_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","volume":"36","author":"T Bo","year":"2024","unstructured":"Bo T, Gao L, Yao Z, Shao S, Wang X, Proud CG et al (2024) Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab 36:947\u2013968. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.006","journal-title":"Cell Metab"},{"key":"5980_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210828","volume":"14","author":"S Choung","year":"2019","unstructured":"Choung S, Kim JM, Joung KH, Lee ES, Kim HJ, Ku BJ (2019) Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. PLoS ONE 14:e0210828. https:\/\/doi.org\/10.1371\/journal.pone.0210828","journal-title":"PLoS ONE"},{"key":"5980_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/cc6118","volume":"11","author":"D De Backer","year":"2007","unstructured":"De Backer D, Hollenberg S, Boerma C, Goedhart P, B\u00fcchele G, Ospina-Tascon G et al (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11:R101. https:\/\/doi.org\/10.1186\/cc6118","journal-title":"Crit Care"},{"key":"5980_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.936196","volume":"13","author":"W Du","year":"2022","unstructured":"Du W, Wang L (2022) The crosstalk between liver sinusoidal endothelial cells and hepatic microenvironment in NASH related liver fibrosis. Front Immunol 13:936196. https:\/\/doi.org\/10.3389\/fimmu.2022.936196","journal-title":"Front Immunol"},{"key":"5980_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam M, Fan JG, Yu ML, Wong VW, Cua IH, Liu CJ et al (2025) The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol Int 19:261\u2013301. https:\/\/doi.org\/10.1007\/s12072-024-10774-3","journal-title":"Hepatol Int"},{"issue":"6","key":"5980_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ar.20715","volume":"291","author":"GC Farrell","year":"2008","unstructured":"Farrell GC, Teoh NC, McCuskey RS (2008) Hepatic microcirculation in fatty liver disease. Anat Rec 291(6):684\u2013692","journal-title":"Anat Rec"},{"key":"5980_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jhep.2025.10.017","volume":"84","author":"E Felli","year":"2026","unstructured":"Felli E, Nulan Y, Ortega-Ribera M, Fern\u00e1ndez-Iglesias A, Gracia-Sancho J (2026) The role of liver sinusoidal endothelial cells in liver diseases: key players in health and pathology. J Hepatol 84:655\u2013672. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.017","journal-title":"J Hepatol"},{"key":"5980_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","volume":"16","author":"J Gracia-Sancho","year":"2019","unstructured":"Gracia-Sancho J, Marrone G, Fern\u00e1ndez-Iglesias A (2019) Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol 16:221\u2013234. https:\/\/doi.org\/10.1038\/s41575-018-0097-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5980_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","volume":"18","author":"J Gracia-Sancho","year":"2021","unstructured":"Gracia-Sancho J, Caparr\u00f3s E, Fern\u00e1ndez-Iglesias A, Franc\u00e9s R (2021) Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol 18:411\u2013431. https:\/\/doi.org\/10.1038\/s41575-020-00411-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5980_CR16","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","volume":"70","author":"A Hammoutene","year":"2019","unstructured":"Hammoutene A, Rautou PE (2019) Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol 70:1278\u20131291. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.012","journal-title":"J Hepatol"},{"key":"5980_CR17","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41388-022-02197-x","volume":"41","author":"L Han","year":"2022","unstructured":"Han L, Lin X, Yan Q, Gu C, Li M, Pan L et al (2022) PBLD inhibits angiogenesis via impeding VEGF\/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. Oncogene 41:1851\u20131865. https:\/\/doi.org\/10.1038\/s41388-022-02197-x","journal-title":"Oncogene"},{"key":"5980_CR18","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-2803.24612025-053","volume":"62","author":"AB Hirayama","year":"2025","unstructured":"Hirayama AB, Taliberti IB, Oliveira CPMS, Alves VAF (2025) Lipotoxicity plays a key role in the development of angiogenesis and microcirculatory modulation in MASLD spectrum. Arq Gastroenterol 62:e25053. https:\/\/doi.org\/10.1590\/S0004-2803.24612025-053","journal-title":"Arq Gastroenterol"},{"key":"5980_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/CM9.0000000000003141","volume":"138","author":"M Hou","year":"2025","unstructured":"Hou M, Gu Q, Cui J, Dou Y, Huang X, Li J et al (2025) Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population. Chin Med J (Engl) 138:829\u2013837. https:\/\/doi.org\/10.1097\/CM9.0000000000003141","journal-title":"Chin Med J (Engl)"},{"key":"5980_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL (2022) Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol 22:429\u2013443. https:\/\/doi.org\/10.1038\/s41577-021-00639-3","journal-title":"Nat Rev Immunol"},{"key":"5980_CR21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","volume":"18","author":"R Kirsch","year":"2003","unstructured":"Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE et al (2003) Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18:1272\u201382. https:\/\/doi.org\/10.1046\/j.1440-1746.2003.03198.x","journal-title":"J Gastroenterol Hepatol"},{"key":"5980_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nu17223585","volume":"17","author":"A Koperska","year":"2025","unstructured":"Koperska A, Miller-Kasprzak E, Seraszek-Jaros A, Musialik K, Bogda\u0144ski P, Szuli\u0144ska M (2025) The influence of berberine on vascular function parameters, among them VEGF, in individuals with MAFLD: a double-blind, randomized, placebo-controlled trial. Nutrients 17:3585. https:\/\/doi.org\/10.3390\/nu17223585","journal-title":"Nutrients"},{"key":"5980_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.833414","volume":"13","author":"C Li","year":"2022","unstructured":"Li C, Yu S, Li X et al (2022) Medicinal formula Huazhi-Rougan attenuates non-alcoholic steatohepatitis through enhancing fecal bile acid excretion in mice. Front Pharmacol 13:833414. https:\/\/doi.org\/10.3389\/fphar.2022.833414","journal-title":"Front Pharmacol"},{"key":"5980_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/mmr.2016.5965","volume":"15","author":"Y Li","year":"2017","unstructured":"Li Y, Shi Y, Sun Y, Liu L, Bai X, Wang D et al (2017) Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride. Mol Med Rep 15:47\u201356. https:\/\/doi.org\/10.3892\/mmr.2016.5965","journal-title":"Mol Med Rep"},{"key":"5980_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42358-024-00356-0","volume":"64","author":"J Li","year":"2024","unstructured":"Li J, Xiong J, Liu P, Peng Y, Cai S, Fang X et al (2024) Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus. Adv Rheumatol 64:15. https:\/\/doi.org\/10.1186\/s42358-024-00356-0","journal-title":"Adv Rheumatol"},{"issue":"2","key":"5980_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/0115701646300960240606093535","volume":"21","author":"MC Lin","year":"2024","unstructured":"Lin MC, Lin MW, Sulistyowati E et al (2024) Comparison of the effects of different coating matrices on cell binding and nitric oxide-mediated protein S-nitrosylation in endothelial cells under shear flow. Curr Proteomics 21(2):79\u201387","journal-title":"Curr Proteomics"},{"key":"5980_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.32662","volume":"77","author":"X Liu","year":"2023","unstructured":"Liu X, Tan S, Liu H, Jiang J, Wang X, Li L et al (2023) Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology 77:1181\u20131197. https:\/\/doi.org\/10.1002\/hep.32662","journal-title":"Hepatology"},{"key":"5980_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1399598","volume":"15","author":"P Liu","year":"2024","unstructured":"Liu P, Liang WL, Huang RT, Chen XX, Zou DH, Kurihara H et al (2024) Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine. Front Pharmacol 15:1399598. https:\/\/doi.org\/10.3389\/fphar.2024.1399598","journal-title":"Front Pharmacol"},{"key":"5980_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xu W, Zhai T, You J, Chen Y (2019) Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Acta Pharm Sin B 9:745\u2013757. https:\/\/doi.org\/10.1016\/j.apsb.2019.02.006","journal-title":"Acta Pharm Sin B"},{"key":"5980_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3748\/wjg.v30.i4.290","volume":"30","author":"A Madir","year":"2024","unstructured":"Madir A, Grgurevic I, Tsochatzis EA, Pinzani M (2024) Portal hypertension in patients with nonalcoholic fatty liver disease: current knowledge and challenges. World J Gastroenterol 30:290\u2013307. https:\/\/doi.org\/10.3748\/wjg.v30.i4.290","journal-title":"World J Gastroenterol"},{"key":"5980_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102526","volume":"95","author":"A Martin-Vega","year":"2025","unstructured":"Martin-Vega A, Cobb MH (2025) ERK1\/2-MAPK signaling: metabolic, organellar, and cytoskeletal interactions. Curr Opin Cell Biol 95:102526. https:\/\/doi.org\/10.1016\/j.ceb.2025.102526","journal-title":"Curr Opin Cell Biol"},{"key":"5980_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/nu18061005","volume":"18","author":"A Mavroudis","year":"2026","unstructured":"Mavroudis A, Fragoulis C, Mavromoustakou K, Iliakis P, Tsioufis K, Chrysohoou C (2026) Mechanisms of cardiac inflammation in heart failure: role of dietary patterns, nutrients, and therapeutic strategies. Nutrients 18:1005. https:\/\/doi.org\/10.3390\/nu18061005","journal-title":"Nutrients"},{"issue":"1","key":"5980_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, Rautou PE (2017) Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol 66(1):212\u2013227","journal-title":"J Hepatol"},{"key":"5980_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3350\/cmh.2024.0022","volume":"30","author":"J Qu","year":"2024","unstructured":"Qu J, Wang L, Li Y, Li X (2024) Liver sinusoidal endothelial cell: an important yet often overlooked player in the liver fibrosis. Clin Mol Hepatol 30:303\u2013325. https:\/\/doi.org\/10.3350\/cmh.2024.0022","journal-title":"Clin Mol Hepatol"},{"key":"5980_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2003.10.027","volume":"40","author":"CA Redaelli","year":"2004","unstructured":"Redaelli CA, Semela D, Carrick FE, Ledermann M, Candinas D, Sauter B et al (2004) Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. J Hepatol 40:305\u2013312. https:\/\/doi.org\/10.1016\/j.jhep.2003.10.027","journal-title":"J Hepatol"},{"key":"5980_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1081334","volume":"14","author":"C Song","year":"2023","unstructured":"Song C, Long X, He J, Huang Y (2023) Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease. Front Pharmacol 14:1081334. https:\/\/doi.org\/10.3389\/fphar.2023.1081334","journal-title":"Front Pharmacol"},{"key":"5980_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-025-01119-9","volume":"32","author":"C Tito","year":"2025","unstructured":"Tito C, Masciarelli S, Colotti G, Fazi F (2025) EGF receptor in organ development, tissue homeostasis and regeneration. J Biomed Sci 32:24. https:\/\/doi.org\/10.1186\/s12929-025-01119-9","journal-title":"J Biomed Sci"},{"key":"5980_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803037","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y et al (2021) Macrophage polarization and its role in liver disease. Front Immunol 12:803037. https:\/\/doi.org\/10.3389\/fimmu.2021.803037","journal-title":"Front Immunol"},{"key":"5980_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1495393","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, An J, Zhou J, Chang L, Zhang Q, Peng F (2025) Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect. Front Pharmacol 15:1495393. https:\/\/doi.org\/10.3389\/fphar.2024.1495393","journal-title":"Front Pharmacol"},{"key":"5980_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1055\/s-0039-1685515","volume":"39","author":"A Wree","year":"2019","unstructured":"Wree A, Holtmann TM, Inzaugarat ME, Feldstein AE (2019) Novel drivers of the inflammatory response in liver injury and fibrosis. Semin Liver Dis 39:275\u2013282. https:\/\/doi.org\/10.1055\/s-0039-1685515","journal-title":"Semin Liver Dis"},{"key":"5980_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155830","volume":"132","author":"X Xue","year":"2024","unstructured":"Xue X, Li Y, Zhang S, Yao Y, Peng C, Li Y (2024) Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p\/PDGFRB axis in liver fibrosis. Phytomedicine 132:155830. https:\/\/doi.org\/10.1016\/j.phymed.2024.155830","journal-title":"Phytomedicine"},{"key":"5980_CR42","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan M, Cui Y, Xiang Q (2025) Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics 15:1715\u20131740. https:\/\/doi.org\/10.7150\/thno.106597","journal-title":"Theranostics"},{"key":"5980_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3892\/mmr.2021.11974","volume":"23","author":"L Yang","year":"2021","unstructured":"Yang L, Liu Q, Zhang H, Wang Y, Li Y, Chen S et al (2021) Silibinin improves nonalcoholic fatty liver by regulating the expression of miR-122: an in vitro and in vivo study. Mol Med Rep 23:335. https:\/\/doi.org\/10.3892\/mmr.2021.11974","journal-title":"Mol Med Rep"},{"key":"5980_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4560012","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Shen D, Feng Y, Li Y, Liao H (2021) Pharmacological actions, molecular mechanisms, pharmacokinetic progressions, and clinical applications of hydroxysafflor yellow A in antidiabetic research. J Immunol Res 4560012. https:\/\/doi.org\/10.1155\/2021\/4560012","journal-title":"J Immunol Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05980-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:02:48Z","timestamp":1791478968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05980-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":44,"alternative-id":["5980"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05980-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Laboratory Animal Ethics Committee of Heilongjiang University of Chinese Medicine (Approval No. SCXK(Liao)2020\u20130001). All experiments were conducted in full compliance with the Guide for the Care and Use of Laboratory Animals published by the US National Research Council and reported in accordance with the ARRIVE guidelines. Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.\u00a0","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}